Citigroup Inc news

   Watch this stock
Showing stories 1 - 10 of about 123   

Articles published

C 51.17 +0.64 (1.27%)
price chart
Forex-Rigging Fines Could Hit $41 Billion Globally: Citi
The cost for banks to settle probes into allegations traders rigged foreign-exchange benchmarks could hit as much as $41 billion, Citigroup Inc. (C) analysts said. Deutsche Bank AG (DBK) is seen as probably the �most impacted� with a fine of as much as ...
Currency-Rigging Fines Could Hit $41 Billion Globally, Citi Says  swissinfo.ch
Those banks�$41b in fines for FX rigging  FXstreet.com
Related articles »  
One Reason Citigroup (C) Stock Is Up Today
"We rate CITIGROUP INC (C) a BUY. This is driven by several positive factors, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover.
Why I'm Adding Citigroup To My Portfolio Today (C)
A withdrawal of retail operations in 11 markets signals an easing of global growth and expansion plans and a renewed focus on expanding operating margins.
Citi To Give Out Credit-Score Details To Customers
Citigroup Inc (C) will now allow credit-card holders to check their credit scores, reported The Wall Street Journal. Citi is the fourth-largest credit-card issuer in the country in terms of volume and is joining hands with credit-score provider Fair ...
Related articles »  
Citigroup Inc Beats Estimates, To Exit Some Consumer Markets
Citigroup Inc (NYSE:C) released the earnings results from its third quarter before opening bell this morning, posting earnings of $1.15 per share, excluding CVA / DVA, on $20 billion in revenue, excluding CVA / DVA.
UPDATE: Citigroup Shares Gain On Upbeat Q3 Profit  Benzinga
Citigroup to Exit Consumer Banking in 11 Markets  Bloomberg
Related articles »  
Citi: At Least 14% Upside (C)
After struggling for several years, Citi is a strongly capitalized bank that should soon be allowed to return capital to shareholders.
Ambit Biosciences Corp Stock Rating Lowered by Citigroup Inc. (AMBI)
Citigroup Inc. lowered shares of Ambit Biosciences Corp (NASDAQ:AMBI) from a buy rating to a neutral rating in a research report released on Monday morning, TheFlyOnTheWall.
Ambit Biosciences Corp Rating Lowered to Neutral at Citigroup Inc. (AMBI)  WKRB News
Citi, JP Morgan, Wells Fargo: 3Q Earnings Release Comparison
However, the reported quarterly net income was lowest for Citi, amounting to $3.44 billion or $1.07 per share, compared to Wells Fargo's $5.41 billion or $1.02 per share.
Exelon Upgraded to Neutral by Citigroup Inc. (EXC)
Exelon Co. logo Citigroup Inc. upgraded shares of Exelon (NYSE:EXC) from a sell rating to a neutral rating in a research report released on Friday morning, TheFlyOnTheWall.
Exelon Rating Increased to Neutral at Citigroup Inc. (EXC)  Ticker Report
Related articles »  
Braskem SA Stock Rating Upgraded by Citigroup Inc. (BAK)
Citigroup Inc. has also updated their ratings on a number of other basic materials stocks in the last week. The firm upgraded shares of Alliance Holdings GP, L.P.
Related articles »